Startup SiteOne Secures $100M to Forge Ahead With Novel Non-Opioid Pain Meds
SiteOne Therapeutics develops drugs that target sodium channels, the “wiring” in the body that transmits pain signals. Because SiteOne’s targets are located in the peripheral nervous system, they should not pose the same addiction risks as opioids, which hit receptors in the central nervous system.
The AI Advantage: Reimagining the Future of Drug Development
Like any other tool, understanding the right problem to apply it to is the difference between success and failure. Addressing a problem is never just about technology; it’s always about people, processes, and technology.
Future Trends for Clinical Trials in 2025 and Beyond
Four key predictions for the future of clinical trials, examining how these changes will revolutionize the speed, efficiency, and reliability of bringing life-saving treatments to market.
FDA Clears Withings’ New Blood Pressure Monitor That Allows Providers to Communicate Directly with Patients
This week, the FDA granted clearance to Withings’ BPM Pro 2 cellular blood pressure monitor. The device seeks to help providers scale remote patient monitoring for heart failure patients.